Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Licenses offered for marker in the human iNOS gene promoter region

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Dec. 18, 1996

Beacon obtains rights to Centocor tumor markers

Dec. 18, 1996

New imaging agents for 19F MRI claimed by Molecular Biosystems

Dec. 17, 1996

CRC and Cortecs to develop cancer diagnostic tests

Dec. 16, 1996

Oncogene Science and Bayer initiate cancer diagnostics collaboration

Dec. 16, 1996

Oncor expands marketing of breast cancer test

Dec. 16, 1996

Faulding receives approval for generic contrast media

Dec. 13, 1996

BioProCon to market DiagnoCure bladder cancer diagnostic

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...